- Home
- IGC vs ARBB Comparison
IGC vs ARBB Comparison
Compare IGC & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- ARBB
- Stock Information
- Founded
- IGC 2005
- ARBB 1997
- Country
- IGC United States
- ARBB Singapore
- Employees
- IGC N/A
- ARBB N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- ARBB EDP Services
- Sector
- IGC Health Care
- ARBB Technology
- Exchange
- IGC Nasdaq
- ARBB Nasdaq
- Market Cap
- IGC 18.0M
- ARBB 18.0M
- IPO Year
- IGC N/A
- ARBB 2023
- Fundamental
- Price
- IGC $0.28
- ARBB $0.76
- Analyst Decision
- IGC Strong Buy
- ARBB
- Analyst Count
- IGC 2
- ARBB 0
- Target Price
- IGC $3.88
- ARBB N/A
- AVG Volume (30 Days)
- IGC 241.5K
- ARBB 5.0M
- Earning Date
- IGC 02-18-2025
- ARBB 04-26-2025
- Dividend Yield
- IGC N/A
- ARBB N/A
- EPS Growth
- IGC N/A
- ARBB N/A
- EPS
- IGC N/A
- ARBB N/A
- Revenue
- IGC $1,236,000.00
- ARBB $12,334,474.00
- Revenue This Year
- IGC N/A
- ARBB N/A
- Revenue Next Year
- IGC $18.34
- ARBB N/A
- P/E Ratio
- IGC N/A
- ARBB N/A
- Revenue Growth
- IGC 1.65
- ARBB N/A
- 52 Week Low
- IGC $0.25
- ARBB $0.22
- 52 Week High
- IGC $0.66
- ARBB $1.33
- Technical
- Relative Strength Index (RSI)
- IGC 45.11
- ARBB 53.75
- Support Level
- IGC $0.25
- ARBB $0.53
- Resistance Level
- IGC $0.29
- ARBB $1.09
- Average True Range (ATR)
- IGC 0.02
- ARBB 0.10
- MACD
- IGC 0.00
- ARBB 0.01
- Stochastic Oscillator
- IGC 60.00
- ARBB 40.97
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.